ALNOV:EPA
Novacyt SA
0,41 €
0,00%
(0,00) 1D
6 ნოე, 17:35:21 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNOV...
Open
0,41 €
High
0,41 €
Low
0,40 €
Mkt. cap
27,19 მლნ.
Avg. vol.
187,71 ათ.
Volume
119,78 ათ.
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,38 €
Shares outstanding
72,59 მლნ.
No. of employees
228
Open
0,41 €
High
0,41 €
Low
0,40 €
Mkt. cap
27,19 მლნ.
Avg. vol.
187,71 ათ.
Volume
119,78 ათ.
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,38 €
Shares outstanding
72,59 მლნ.
No. of employees
228
News stories
From web sources and news partners
USA Today
·
24 წუთის წინ
Stagwell Inc. (STGW) Reports Equity Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance
·
52 წუთის წინ
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Los Angeles Times
·
6 წუთის წინ
AI stocks halt their brutal, worldwide sell-off as Wall Street trims its loss for the week
The Motley Fool
·
37 წუთის წინ
Midterms Are Over. Here's What History Says the S&P 500 Does Next.
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA
CEOდავიდ ალმონდ
Employees228
Founded3 ივლ. 2006
Headquarters-
SectorHealth Care
Industry-
Websitenovacyt.com